General Law Committee
JOINT FAVORABLE REPORT
Bill No.: SB-694
AN ACT CONCERNING REVISIONS TO PHARMACY AND DRUG CONTROL
Title: STATUTES.
Vote Date: 3/9/2021
Vote Action: Joint Favorable Substitute
PH Date: 2/25/2021
File No.: 108
Disclaimer: The following JOINT FAVORABLE Report is prepared for the benefit of the
members of the General Assembly, solely for purposes of information, summarization and
explanation and does not represent the intent of the General Assembly or either chamber
thereof for any purpose.
SPONSORS OF BILL:
General Law Committee
REASONS FOR BILL:
This bill will allow for DCP to make changes to current statutes. Though some are technical
changes; this also allows DCP additional ways to protect the health and safety of the public.
Substitute language
Section 2 is amended which allows pharmacists to prescribe EpiPens under certain
circumstances. The Medical Society was concerned about patients avoiding routine
preventative care with PCP's. The change limits the number of times a patient can receive
prescription from their pharmacist to once per year. This is an effort to ensure that patients
continue to see their PCP's for preventative care.
The notice to DCP for the remodeling or relocation of sterile compounding pharmacies. Prior
to the substitute language the change would be from 10 days to 60 days, however last year it
was requested by the Connecticut Hospital Association and Pharmacist Association be
reduced from 60 to 45 days.
RESPONSE FROM ADMINISTRATION/AGENCY:
Michelle Seagull, Commissioner, Department of Consumer Protection
Comm. Seagull supports this bill, it was requested by the DCP. This bill makes multiple
changes to the drug control statutes. There are technical changes, but also additional tools
to protect the health and safety of the public
NATURE AND SOURCES OF SUPPORT:
Connecticut Hospital Association
CHA supports this bill. This bill will make changes to ensure patients have access to
important medications
Sean Jeffrey, PharmD, Director of Clinical Pharmacy Services, Integrated Care
Partners, Hartford Healthcare
Sean Jeffrey states that they are in favor of this bill. The changes are reasonable. Among
the provisions is that pharmacies provide earlier notice to the DCP Drug Control Division of
any planned remodeling or relocation of a sterile compound space. These types of changes
are planned well in advance.
Nathan Tinker, CEO, Connecticut Pharmacists Association
CPA is in support of this bill with the change request to have sterile compound remodeling
plans be 45 days, not 60. Allowing pharmacists under certain conditions to prescribe and
dispense EpiPens. EpiPens are a medical necessity and can be life-saving. This will
eliminate the logistical hassle that is sometimes a barrier for patients. This is a welcome
public health arsenal.
NATURE AND SOURCES OF OPPOSITION:
None Expressed
Reported by: Bonnie Gray, Asst. Clerk Date: 3/19/2021
Page 2 of 2 SB-694


Statutes affected:
Raised Bill:
GL Joint Favorable Substitute:
File No. 108: